IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v535y2016i7610d10.1038_nature18621.html
   My bibliography  Save this article

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Author

Listed:
  • Ying-Nan P. Chen

    (Novartis Institutes for Biomedical Research)

  • Matthew J. LaMarche

    (Novartis Institutes for Biomedical Research)

  • Ho Man Chan

    (Novartis Institutes for Biomedical Research)

  • Peter Fekkes

    (Novartis Institutes for Biomedical Research)

  • Jorge Garcia-Fortanet

    (Novartis Institutes for Biomedical Research)

  • Michael G. Acker

    (Novartis Institutes for Biomedical Research)

  • Brandon Antonakos

    (Novartis Institutes for Biomedical Research)

  • Christine Hiu-Tung Chen

    (Novartis Institutes for Biomedical Research)

  • Zhouliang Chen

    (Novartis Institutes for Biomedical Research)

  • Vesselina G. Cooke

    (Novartis Institutes for Biomedical Research)

  • Jason R. Dobson

    (Novartis Institutes for Biomedical Research)

  • Zhan Deng

    (Novartis Institutes for Biomedical Research)

  • Feng Fei

    (Novartis Institutes for Biomedical Research)

  • Brant Firestone

    (Novartis Institutes for Biomedical Research)

  • Michelle Fodor

    (Novartis Institutes for Biomedical Research)

  • Cary Fridrich

    (Novartis Institutes for Biomedical Research)

  • Hui Gao

    (Novartis Institutes for Biomedical Research)

  • Denise Grunenfelder

    (Novartis Institutes for Biomedical Research)

  • Huai-Xiang Hao

    (Novartis Institutes for Biomedical Research)

  • Jaison Jacob

    (Novartis Institutes for Biomedical Research)

  • Samuel Ho

    (Novartis Institutes for Biomedical Research)

  • Kathy Hsiao

    (Novartis Institutes for Biomedical Research)

  • Zhao B. Kang

    (Novartis Institutes for Biomedical Research)

  • Rajesh Karki

    (Novartis Institutes for Biomedical Research)

  • Mitsunori Kato

    (Novartis Institutes for Biomedical Research)

  • Jay Larrow

    (Novartis Institutes for Biomedical Research)

  • Laura R. La Bonte

    (Novartis Institutes for Biomedical Research)

  • Francois Lenoir

    (Novartis Institutes for Biomedical Research)

  • Gang Liu

    (Novartis Institutes for Biomedical Research)

  • Shumei Liu

    (Novartis Institutes for Biomedical Research)

  • Dyuti Majumdar

    (Novartis Institutes for Biomedical Research)

  • Matthew J. Meyer

    (Novartis Institutes for Biomedical Research)

  • Mark Palermo

    (Novartis Institutes for Biomedical Research)

  • Lawrence Perez

    (Novartis Institutes for Biomedical Research)

  • Minying Pu

    (Novartis Institutes for Biomedical Research)

  • Edmund Price

    (Novartis Institutes for Biomedical Research)

  • Christopher Quinn

    (Novartis Institutes for Biomedical Research)

  • Subarna Shakya

    (Novartis Institutes for Biomedical Research)

  • Michael D. Shultz

    (Novartis Institutes for Biomedical Research)

  • Joanna Slisz

    (Novartis Institutes for Biomedical Research)

  • Kavitha Venkatesan

    (Novartis Institutes for Biomedical Research)

  • Ping Wang

    (Novartis Institutes for Biomedical Research)

  • Markus Warmuth

    (Novartis Institutes for Biomedical Research)

  • Sarah Williams

    (Novartis Institutes for Biomedical Research)

  • Guizhi Yang

    (Novartis Institutes for Biomedical Research)

  • Jing Yuan

    (Novartis Institutes for Biomedical Research)

  • Ji-Hu Zhang

    (Novartis Institutes for Biomedical Research)

  • Ping Zhu

    (Novartis Institutes for Biomedical Research)

  • Timothy Ramsey

    (Novartis Institutes for Biomedical Research)

  • Nicholas J. Keen

    (Novartis Institutes for Biomedical Research)

  • William R. Sellers

    (Novartis Institutes for Biomedical Research)

  • Travis Stams

    (Novartis Institutes for Biomedical Research)

  • Pascal D. Fortin

    (Novartis Institutes for Biomedical Research)

Abstract

SHP099, a selective inhibitor of signalling meditator SHP2 with drug-like properties, has an allosteric mechanism of action whereby it stabilizes SHP2 in an auto-inhibited conformation, and suppresses RAS–ERK signalling and proliferation in receptor-tyrosine-kinase-driven cancer cell lines and mouse tumour xenograft models.

Suggested Citation

  • Ying-Nan P. Chen & Matthew J. LaMarche & Ho Man Chan & Peter Fekkes & Jorge Garcia-Fortanet & Michael G. Acker & Brandon Antonakos & Christine Hiu-Tung Chen & Zhouliang Chen & Vesselina G. Cooke & Jas, 2016. "Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases," Nature, Nature, vol. 535(7610), pages 148-152, July.
    • Handle: RePEc:nat:nature:v:535:y:2016:i:7610:d:10.1038_nature18621
    DOI: 10.1038/nature18621
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature18621
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature18621?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fenli Shao & Qianqian Liu & Yuyu Zhu & Zhidan Fan & Wenjun Chen & Shijia Liu & Xiaohui Li & Wenjie Guo & Gen-Sheng Feng & Haiguo Yu & Qiang Xu & Yang Sun, 2021. "Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    2. Takayoshi Shirasaki & Satoshi Yamagoe & Tetsuro Shimakami & Kazuhisa Murai & Ryu Imamura & Kiyo-Aki Ishii & Hiroaki Takayama & Yukako Matsumoto & Natsumi Tajima-Shirasaki & Naoto Nagata & Ryogo Shimiz, 2022. "Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Surbhi Chouhan & Dhivya Sridaran & Cody Weimholt & Jingqin Luo & Tiandao Li & Myles C. Hodgson & Luana N. Santos & Samantha Sommer & Bin Fang & John M. Koomen & Markus Seeliger & Cheng-Kui Qu & Armell, 2024. "SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    4. Tanaz Sharifnia & Mathias J. Wawer & Amy Goodale & Yenarae Lee & Mariya Kazachkova & Joshua M. Dempster & Sandrine Muller & Joan Levy & Daniel M. Freed & Josh Sommer & Jérémie Kalfon & Francisca Vazqu, 2023. "Mapping the landscape of genetic dependencies in chordoma," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    5. Teklab Gebregiworgis & Yoshihito Kano & Jonathan St-Germain & Nikolina Radulovich & Molly L. Udaskin & Ahmet Mentes & Richard Huang & Betty P. K. Poon & Wenguang He & Ivette Valencia-Sama & Claire M. , 2021. "The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    6. Peter G. Miller & Murugappan Sathappa & Jamie A. Moroco & Wei Jiang & Yue Qian & Sumaiya Iqbal & Qi Guo & Andrew O. Giacomelli & Subrata Shaw & Camille Vernier & Besnik Bajrami & Xiaoping Yang & Ceris, 2022. "Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    7. Zhiyong Xu & Chunyi Guo & Qiaoli Ye & Yueli Shi & Yihui Sun & Jie Zhang & Jiaqi Huang & Yizhou Huang & Chunlai Zeng & Xue Zhang & Yuehai Ke & Hongqiang Cheng, 2021. "Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    8. Shiyun Cao & Shoukai Kang & Haibin Mao & Jiayu Yao & Liangcai Gu & Ning Zheng, 2022. "Defining molecular glues with a dual-nanobody cannabidiol sensor," Nature Communications, Nature, vol. 13(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:535:y:2016:i:7610:d:10.1038_nature18621. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.